NCT05006794 2026-01-07Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid MalignanciesGilead SciencesPhase 1 Active not recruiting145 enrolled